Market Snapshot

Market Snapshot

Infectious Diseases Rapid Diagnostic Testing Market by Growth Rates, %

Market Overview

Market Overview

In the recent times, the global outbreak of COVID-19 has resulted in an increased demand for rapid diagnostic testing. This causes a growth in the rapid diagnostic testing market. The increase in incidence of pandemics is likely to cause a rapid increase in rapid diagnostic assays, decentralised laboratories and more budget for R&D activities. The level of strain on the healthcare system is rising due to the growing infection rates. The focus of the governments on bolstering the healthcare systems is causing a need for better diagnostic testing systems.

The market for infectious rapid diagnostic testing is used for identifying various infectious diseases within a restricted clinical environment. The success of the testing depends on quickly identifying the target analyte within a set time frame. These diagnostic tests play a critical role in navigating through pandemics such as Ebola virus disease (EVD), SARS-CoV, MERS and COVID-19.

Uncover key market trends, investment insights, and global economic impacts driving this industry's growth
Download Free Overview Report

Porter 5

Market Segmentation

Company Performance

Financial values in the chart are available after report is purchased.

Our Company Coverage

Our comprehensive company performance report offers a detailed analysis of critical factors for our clients' industry insights. It covers key financial metrics, such as revenue, profit, and profit margin, providing a clear financial overview. We also assess the company's structure by identifying key subsidiaries and top industry competitors, conducting a thorough SWOT analysis to reveal strengths, weaknesses, opportunities, and threats. The report includes an in-depth income statement for financial assessment and a credit analysis for evaluating creditworthiness. Industry-specific data and benchmarks enable clients to compare performance, providing actionable insights for strategic decisions and competitive advantages.

Corporate Information

Main activities
Number of employees
Key executives
Company Description
Similar companies
Ownership details
Financial Performance Charts
Top Competitors
Similar companies
Ownership details
Financial Performance Charts
Top Competitors

Corporate Information

Income statement
Credit analysis
Credit analysis
Benchmark score

Depending on the size and type of the organisation we may also provide:

News: Business/financial results, investments and deals
Reports: Annual reports, broker reports
M&A: Information on past deals, deal intents
Discover the industry's latest trends, global economic factors, and impactful investments driving its expansion.
Download Free Sample
Download Free Sample

Table of Contents

Table of Contents

1. Research Methodology and Scope

2. Executive Summary

3. Impact of COVID-19 on Infectious Diseases Rapid Testing Market

        3.1 Market Value Estimation Pre-COVID19 vs Post COVID-19

        3.2 Impact of COVID-19 on Market in Different Countries

4. Market Dynamics

        4.1 Drivers

        4.2 Restraints

5. Competitive Landscape

        5.1 Key Strategies Adopted by Major Companies

        5.2 Company Share Analysis

6. Rapid Testing Market Segmentation by Product

        6.1 Assays

        6.2 Platforms

7. Rapid Testing Market Segmentation by Technology

        7.1 Real Time PCR

        7.2 Isothermal Nuclear Acid Amplification Technology (INAAT)

        7.3 Lateral Flow Immunoassays

        7.4 Enzyme Immunoassays

        7.5 Others

8. Rapid Testing Market Segmentation by Application

        8.1 Respiratory Infection

        8.2 Gastro-Intestinal Infection

        8.3 Nervous System Infection

        8.4 Hospital Acquired Infection

        8.5 Sexually Transmitted Infections

        8.5 Others

9. Rapid Testing Market Segmentation by Disease

        9.1 Bacterial Disease

                 9.1.1 Hospital Acquired Infections

                 9.1.2 Tuberculosis

                 9.1.3 CT/NG

                 9.1.4 Others

        9.2 Viral Infections

                 9.2.1 Influenza Virus

                 9.2.2 Hepatitis

                 9.2.3 HIV/AIDS

                 9.2.4 HPV

                 9.2.4 Others

        9.3 Other Infections

10. Rapid Testing Market Segmentation by End User

        10.1 Hospitals

        10.2 Clinics

        10.3 Diagnostic Centres

        10.4 Other End Users

11. Rapid Diagnostic Testing Market by Region

        11.1 North America

                 11.1.1 United States

                 11.1.2 Canada

                 11.1.3 Mexico

        11.2 Europe

                 11.2.1 United Kingdom

                 11.2.2 Spain

                 11.2.3 Italy

                 11.2.4 Germany

                 11.2.5 Russia

                 11.2.6 Rest of Europe

        11.3 Asia-Pacific

                 11.3.1 China

                 11.3.2 India

                 11.3.3 Japan

                 11.3.4 Australia

                 11.3.5 South Korea

                 11.3.6 Rest of Asia-Pacific

        11.4 South America

                 11.4.1 Brazil

                 11.4.2 Rest of South America

        11.5 Middle East and Africa

12. Company Profiles

        12.1 Abbott Laboratories

        12.2 Roche

        12.3 Danaher Corporation

        12.4 Luminex Corporation

        12.5 BGI Group

        12.6 Hologic Inc

        12.7 Thermo Fisher Scientific

        12.8 Becton Dickinson and Company

        12.9 bioMerieux

        12.10 Bio-Rad Laboratories

13. Appendix

Research Methodology

Segmentation by Product

It is estimated that the RT-PCR market will grow from $687.31 million in 2019 to $1621.5 million by 2025. The INAAT technology is expected to grow from $167.3 million in 2019 to $383.5 million in 2025. The Lateral Flow Immunoassay market is expected to grow from $242.9 million to $570.1 million in 2025. The Enzyme Immunoassay market is expected to grow from $105.6 million to $204.6 million in 2025. The other technologies form the remaining share of the market. Some of the key products offered under RT-PCR include ARIES GBS Assay, Accula Flu A/Flu B, Aptima HBV Quant assay, Solana Respiratory Viral Panel and ID NOW COVID-19.

The most recent infections caused across the world have been caused by viruses such as COVID-19, SARS, MERS, Ebola and Zika virus. Bacterial infections such as pneumonia, tuberculosis and malaria also contribute to the increasing disease burden while the remaining infections are caused by other markets. Some of the prominent diseases in this field include Influenza, Viral Infections, Hepatitis, Tuberculosis and Hospital Acquired Infections.

Segmentation by Geography

The most promising countries in terms of the growth of the market include the U.S., Italy, China, India, Brazil and Kingdom of Saudi Arabia. The factors which make U.S. a favourable market for the market include strong legacy and high impact of COVID-19. The rapidly evolving diagnostic landscape and immense growth opportunities make India a promising prospect. The highly effective healthcare system in Italy make the country ideal for the growth of the process.

Major Players

Abbott Laboratories
Abbott Laboratories